Richard Roxburgh: Young kiwi to be first to trial new muscular dystrophy drug - The Mike Hosking Breakfast

A young kiwi patient will be one of the first to be treated with a radical new treatment for a rare disease. 

The drug will be used to target muscle cells and silence a gene which causes Facioscapulohumeral Muscular Dystrophy.

Neurologist and trial lead Richard Roxburgh says the method is promising.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.